By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Ahead of Parents' Day, a 54-year-old son presented a healthy new life to a 75-year-old mother through liver transplantation.

Industry Giants Gilead Sciences, Bristol Myers Squibb, AbbVie, and Merck & Co. Lead the CompetitionDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added ...

Among patients with hepatocellular carcinoma, MAFLD was not an independent predictor for overall survival or progression-free survival.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

ACG released new guidance for the management of malnutrition in patients with liver disease, including the newly renamed ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

MASLD is a condition where excess fat accumulates in the liver of individuals who consume little to no alcohol.

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...